Beck Bode’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
OCBV
Beck Bode's MRVI Position: Q3 2022 in Review
Beck Bode sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 178,916 shares — an estimated $5.08M sold.
Beck Bode first reported a position in MRVI in Q3 2021 and held it in 4 quarters. The position peaked at $7.86M in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.
- Beck Bode reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
- Beck Bode sold 178,916 Maravai LifeSciences shares in Q3 2022, an estimated $5.08M.
- Beck Bode first reported a position in Maravai LifeSciences in Q3 2021 and held it in 4 quarters.
- Beck Bode's Maravai LifeSciences position peaked at $7.86M in Q3 2021.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.
Based on Beck Bode's 13F filing for Q3 2022, filed 14 Nov 2022.